Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 1 | 226376990 | intron variant | T/C | snv | 0.58 |
|
Neoplasms | 0.820 | 1.000 | 2 | 2011 | 2013 | |||||||
|
1 | 226384782 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1 | 226384782 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1 | 226363828 | intron variant | C/A;G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms | 0.080 | 1.000 | 8 | 2009 | 2019 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 0.667 | 6 | 2008 | 2019 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 0.667 | 6 | 2008 | 2019 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms | 0.060 | 0.833 | 6 | 2009 | 2017 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms | 0.060 | 0.833 | 6 | 2009 | 2017 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Digestive System Diseases; Neoplasms | 0.050 | 0.800 | 5 | 2009 | 2014 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Digestive System Diseases; Neoplasms | 0.050 | 0.800 | 5 | 2009 | 2014 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2012 | 2016 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Digestive System Diseases; Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2014 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.030 | 1.000 | 3 | 2012 | 2017 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||||
|
0.925 | 0.080 | 1 | 226385663 | synonymous variant | A/G | snv | 0.43 | 0.42 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2007 | 2018 | ||||||
|
0.925 | 0.080 | 1 | 226385663 | synonymous variant | A/G | snv | 0.43 | 0.42 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2007 | 2018 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2004 | 2005 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2015 | 2019 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2004 | 2005 | ||||||
|
0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2012 | 2017 |